Active substance: Orlistat
Drug treatment of non-insulin-dependent diabetes mellitus in the 1990 s: achievements and future developments. Drugs, 1997, 54, 355-368.
Oral antidiabetic agents: a guide to selection. Drugs, 1998, 55, 225-236. Pharmacologic therapy for type 2 diabetes mellitus.
Ann Intern Med, 1999, 131, 281-303. Drugs used in the treatment of obesity. Diabetes Rev, 1997, 83-103. Pharmacological treatment of obesity: present status. Int J Obes, 1999, 23, 47-53. Pharmacological treatment of the obese diabetic patient.
Diab Metab, 1993, 19, 547-559.
Anorectic agents in non-insulin dependent diabetes mellitus. Curr Opin Endocrinol Diab, 1997, 36-39.
Antiobesity pharmacotherapy in the management of type 2 diabetes. Click here to see the Library ] [ 33 Scheen AJ. Treatment of diabetes in patients with severe obesity. Biomed Pharmacother,, 54, 74-79. Pharmacological approaches for the treatment of obesity.
Drugs,, 62, 915-944.
N Engl J Med,, 346, 591-602. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obesity,, 26, 262-273. Click here to see the Library ] [ 37 Scheen AJ.
Results of obesity treatment. Ann Endocrinol,, 63, 163-170. Most placebo-controlled, double-blind clinical trials lasted 12 weeks and only very few studies were prolonged up to 1 year or more [ 38 Redmon JB, Raatz SK, Kwong CA et al.
Pharmacological induction of weight loss to treat type 2 diabetes. Diabetes Care, 1999, 22, 896-903.